SCHEMBL5154058

SCHEMBL5154058

CCCCCCC(CC)COCC(O)CO

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.61
LMNA P02545 3/20 0.52
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 2/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP3A4 P08684 4/20 0.45
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
HTT P42858 2/20 0.42
CYP2D6 P10635 2/20 0.41
SPHK1 Q9NYA1 1/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153482 1.00 USP2 (0.61) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL6225681 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL15435147 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL27595598 0.93 ALDH1A1 (0.55) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL2878051 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL99276 0.93 ALDH1A1 (0.55) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL6664880 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL10799760 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL19462801 0.93 ALDH1A1 (0.55) USP2LMNAALDH1A1KDM4EDUSP3
SCHEMBL258069 0.93 USP2 (0.65) USP2LMNAALDH1A1KDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1738803-A1 Inhibitors of staphylococcus hominis in deodorants and antiperspirants Henkel Kommanditgesellschaft auf Aktien (DE) 2007-01-03 EP claimed
EP-1576946-A1 Use of inhibitors of gram-positive cocci in deodorants and antiperspirants Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-21 EP claimed
EP-1430933-A2 Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-23 EP claimed
EP-1393518-A2 ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-03-03 EP claimed
WO-2001099376-A2 ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-12-27 WO claimed
EP-1738803-A1 Inhibitors of staphylococcus hominis in deodorants and antiperspirants Henkel Kommanditgesellschaft auf Aktien (DE) 2007-01-03 EP disclosed
EP-1576946-A1 Use of inhibitors of gram-positive cocci in deodorants and antiperspirants Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-21 EP disclosed
EP-1430933-A2 Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-23 EP disclosed
EP-1393518-A2 ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-03-03 EP disclosed
WO-2001099376-A2 ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-12-27 WO disclosed